This is a preview of subscription content, log in via an institution to check access.
Notes
Refractory Overactive Bladder: Sacral Neuromodulation (SNM) versus OnabotulinumtoxinA (BTX) Assessment
Reference
Harvie HS, et al. Cost Effectiveness of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial. Journal of Urology : 101097JU0000000000000656, 18 Nov 2019. Available from: URL: http://doi.org/10.1097/JU.0000000000000656
Rights and permissions
About this article
Cite this article
Sacral neuromodulation not good value in overactive bladder. PharmacoEcon Outcomes News 842, 27 (2019). https://doi.org/10.1007/s40274-019-6419-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6419-z